Current Locations:Home > PRODUCTS > IBI301

IBI301-A Monoclonal Antibody Against CD20

Indicated for the treatment of non-Hodgkin lymphoma (NHL), lymphocytic leukemia, and rheumatoid arthritis (RA); there are over 60 thousands new cases of NHL in China every year.  These patients have limited treatment options. IBI301 targets and attack cells that have CD20 marker on their surface both directly and together with the body’s immune system.

Copyright © 2011- Innovent Biologics, Inc.
Powered by RuiXi